| “UniCAR”-modified off-the-shelf NK-92 cells for targeting of GD2-expressing tumour cells N Mitwasi, A Feldmann, C Arndt, S Koristka, N Berndt, J Jureczek, ... Scientific reports 10 (1), 2141, 2020 | 87 | 2020 |
| Versatile chimeric antigen receptor platform for controllable and combinatorial T cell therapy A Feldmann, A Hoffmann, R Bergmann, S Koristka, N Berndt, C Arndt, ... Oncoimmunology 9 (1), 1785608, 2020 | 55 | 2020 |
| Development of novel target modules for retargeting of UniCAR T cells to GD2 positive tumor cells N Mitwasi, A Feldmann, R Bergmann, N Berndt, C Arndt, S Koristka, ... Oncotarget 8 (65), 108584, 2017 | 48 | 2017 |
| UniCAR T cell immunotherapy enables efficient elimination of radioresistant cancer cells C Arndt, LR Loureiro, A Feldmann, J Jureczek, R Bergmann, D Máthé, ... Oncoimmunology 9 (1), 1743036, 2020 | 34 | 2020 |
| A theranostic PSMA ligand for PET imaging and retargeting of T cells expressing the universal chimeric antigen receptor UniCAR C Arndt, A Feldmann, S Koristka, M Schäfer, R Bergmann, N Mitwasi, ... Oncoimmunology 8 (11), 1659095, 2019 | 30 | 2019 |
| Targeting acute myeloid leukemia using the RevCAR platform: a programmable, switchable and combinatorial strategy E Kittel-Boselli, KEG Soto, LR Loureiro, A Hoffmann, R Bergmann, ... Cancers 13 (19), 4785, 2021 | 24 | 2021 |
| Highly Efficient Targeting of EGFR-Expressing Tumor Cells with UniCAR T Cells via Target Modules Based on Cetuximab® J Jureczek, A Feldmann, R Bergmann, C Arndt, N Berndt, S Koristka, ... OncoTargets and therapy, 5515-5527, 2020 | 20 | 2020 |
| Development and functional characterization of a versatile radio-/immunotheranostic tool for prostate cancer management C Arndt, R Bergmann, F Striese, K Merkel, D Máthé, LR Loureiro, ... Cancers 14 (8), 1996, 2022 | 12 | 2022 |
| Validation of CD98hc as a therapeutic target for a combination of radiation and immunotherapies in head and neck squamous cell carcinoma AS Köseer, LR Loureiro, J Jureczek, N Mitwasi, KE González Soto, ... Cancers 14 (7), 1677, 2022 | 10 | 2022 |
| A novel revcar platform for switchable and gated tumor targeting A Feldmann, A Hoffmann, E Kittel-Boselli, R Bergmann, S Koristka, ... Blood 134, 5611, 2019 | 8 | 2019 |
| Specific and safe targeting of glioblastoma using switchable and logic-gated RevCAR T cells HA Saleh, N Mitwasi, M Ullrich, M Kubeil, M Toussaint, W Deuther-Conrad, ... Frontiers in Immunology 14, 1166169, 2023 | 6 | 2023 |
| A novel ACE2 decoy for both neutralization of SARS-CoV-2 variants and killing of infected cells A Kegler, L Drewitz, C Arndt, C Daglar, L Rodrigues Loureiro, N Mitwasi, ... Frontiers in Immunology 14, 1204543, 2023 | 5 | 2023 |
| Targeting CD10 on b-cell leukemia using the universal CAR T-cell platform (UniCAR) N Mitwasi, C Arndt, LR Loureiro, A Kegler, F Fasslrinner, N Berndt, ... International Journal of Molecular Sciences 23 (9), 4920, 2022 | 5 | 2022 |
| Targeting colorectal cancer cells using AND-gated adaptor RevCAR T-cells KEG Soto, LR Loureiro, T Bartsch, C Arndt, A Kegler, N Mitwasi, L Drewitz, ... Frontiers in Immunology 14, 1302354, 2023 | 4 | 2023 |
| FLT3‐directed UniCAR T‐cell therapy of acute myeloid leukaemia JC Peschke, R Bergmann, M Mehnert, KE González Soto, LR Loureiro, ... British Journal of Haematology 202 (6), 1137-1150, 2023 | 4 | 2023 |
| Combining Radiation-with Immunotherapy in Prostate Cancer: Influence of Radiation on T Cells D Lindner, C Arndt, LR Loureiro, A Feldmann, A Kegler, S Koristka, ... International Journal of Molecular Sciences 23 (14), 7922, 2022 | 2 | 2022 |
| Development of novel anti-CD10 target modules for redirection of universal CAR T cells against CD10-positive malignancies A Feldmann, S Koristka, C Arndt, LR Loureiro, R Bergmann, N Berndt, ... Blood 134, 5612, 2019 | 2 | 2019 |
| RevCAR-expressing immune effector cells for targeting of Fn14-positive glioblastoma HA Saleh, N Mitwasi, L R. Loureiro, A Kegler, KEG Soto, L Hoffmann, ... Cancer Gene Therapy, 1-12, 2024 | 1 | 2024 |
| 45P The RevCAR T cell platform: a switchable and combinatorial therapeutic strategy for glioblastoma N Mitwasi, H Hassan, C Arndt, L Loureiro, C Neuber, A Kegler, M Kubeil, ... Immuno-Oncology and Technology 16, 2022 | 1 | 2022 |
| Antigen-specific redirection of immune effector cells against GD2-expressing tumors NMJ Mitwasi Technische Universität Dresden, 2019 | 1 | 2019 |
